To patienter ud af 16 døde af levernedbrydning og fremskreden portal hypertension efter at have skiftet fra penicillamin til zinkbehandling.
Two patients of a series of 16 died from hepatic decompensation and advanced portal hypertension after being changed from penicillamine to zinc therapy.